225 related articles for article (PubMed ID: 29430333)
1. An Assessment of Five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used Symptoms Rating Scales in Schizophrenia and Comparison to Newer Scales (CAINS, BNSS).
Kumari S; Malik M; Florival C; Manalai P; Sonje S
J Addict Res Ther; 2017; 8(3):. PubMed ID: 29430333
[TBL] [Abstract][Full Text] [Related]
2. Tools to assess negative symptoms in schizophrenia.
Kane JM
J Clin Psychiatry; 2013 Jun; 74(6):e12. PubMed ID: 23842020
[TBL] [Abstract][Full Text] [Related]
3. Defining and measuring negative symptoms of schizophrenia in clinical trials.
Marder SR; Kirkpatrick B
Eur Neuropsychopharmacol; 2014 May; 24(5):737-43. PubMed ID: 24275698
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
[TBL] [Abstract][Full Text] [Related]
5. The Latent Structure of Negative Symptoms in Schizophrenia.
Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
Rekhi G; Alphs L; Ang MS; Lee J
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
[TBL] [Abstract][Full Text] [Related]
7. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
[TBL] [Abstract][Full Text] [Related]
8. Issues in selection of instruments to measure negative symptoms.
Daniel DG
Schizophr Res; 2013 Nov; 150(2-3):343-5. PubMed ID: 23899996
[TBL] [Abstract][Full Text] [Related]
9. Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.
Garcia-Alvarez L; Garcia-Portilla MP; Saiz PA; Fonseca-Pedrero E; Bobes-Bascaran MT; Gomar J; Muñiz J; Bobes J
Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(3):169-175. PubMed ID: 29628403
[TBL] [Abstract][Full Text] [Related]
10. Clinical picture, pathogenesis and psychometric assessment of negative symptoms of schizophrenia.
Wójciak P; Rybakowski J
Psychiatr Pol; 2018 Apr; 52(2):185-197. PubMed ID: 29975360
[TBL] [Abstract][Full Text] [Related]
11. Validation of the traditional script Chinese version of the brief negative symptom scale.
Sun J; Ching EWK; Strauss GP; Ahmed AO; Chui WWH; Chow JSY
Asian J Psychiatr; 2021 Jan; 55():102522. PubMed ID: 33360707
[TBL] [Abstract][Full Text] [Related]
12. [Scale for assessing negative symptoms in schizophrenia: A systematic review].
Mach C; Dollfus S
Encephale; 2016 Apr; 42(2):165-71. PubMed ID: 26923997
[TBL] [Abstract][Full Text] [Related]
13. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
Masiak M; Loza B
Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
[TBL] [Abstract][Full Text] [Related]
14. Validation of Turkish version of brief negative symptom scale.
Polat Nazlı I; Ergül C; Aydemir Ö; Chandhoke S; Üçok A; Gönül AS
Int J Psychiatry Clin Pract; 2016 Nov; 20(4):265-71. PubMed ID: 27409157
[TBL] [Abstract][Full Text] [Related]
15. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Korean-Version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS).
Jung SI; Woo J; Kim YT; Kwak SG
J Korean Med Sci; 2016 Jul; 31(7):1114-20. PubMed ID: 27366011
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia.
Haro JM; Kamath SA; Ochoa S; Novick D; Rele K; Fargas A; Rodríguez MJ; Rele R; Orta J; Kharbeng A; Araya S; Gervin M; Alonso J; Mavreas V; Lavrentzou E; Liontos N; Gregor K; Jones PB;
Acta Psychiatr Scand Suppl; 2003; (416):16-23. PubMed ID: 12755850
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Brief Negative Symptom Scale and its association with functioning.
Ang MS; Rekhi G; Lee J
Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
[TBL] [Abstract][Full Text] [Related]
19. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Engel M; Fritzsche A; Lincoln TM
Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
[TBL] [Abstract][Full Text] [Related]
20. A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale.
Mucci A; Vignapiano A; Bitter I; Austin SF; Delouche C; Dollfus S; Erfurth A; Fleischhacker WW; Giordano GM; Gladyshev I; Glenthøj B; Gütter K; Hofer A; Hubeňák J; Kaiser S; Libiger J; Melle I; Nielsen MØ; Papsuev O; Rybakowski JK; Sachs G; Üçok A; Wojciak P; Galderisi S
Eur Neuropsychopharmacol; 2019 Aug; 29(8):947-959. PubMed ID: 31255394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
